Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hua Hong (often referred to as Hua Hong Pian or Hua Hong Tablet) is a well-established Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of gynecological inflammatory conditions. It is developed and manufactured by Guangxi Huahong Pharmaceutical. The product is composed of several botanical extracts, including *Spatholobus suberectus* (Ji Xue Teng), *Sargentodoxa cuneata* (Da Xue Teng), *Phellodendron chinense* (Huang Bai), *Taraxacum mongolicum* (Pu Gong Ying), *Paeonia lactiflora* (Chi Shao), *Cyperus rotundus* (Xiang Fu), and *Smilax china* (Jin Gang Teng). Hua Hong is clinically indicated for chronic pelvic inflammatory disease (PID), adnexitis, and endometritis, where it is believed to exert anti-inflammatory, analgesic, and blood-circulating effects to resolve damp-heat stasis in the lower burner.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hua Hong.